Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2001 6
2002 8
2003 5
2004 2
2005 6
2006 4
2007 2
2008 7
2009 3
2010 4
2011 3
2012 3
2013 8
2014 3
2015 4
2016 5
2017 6
2018 11
2019 6
2020 2
2021 4
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

105 results
Results by year
Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Mazieres J, Drilon A, Lusque A, Mhanna L, Cortot AB, Mezquita L, Thai AA, Mascaux C, Couraud S, Veillon R, Van den Heuvel M, Neal J, Peled N, Früh M, Ng TL, Gounant V, Popat S, Diebold J, Sabari J, Zhu VW, Rothschild SI, Bironzo P, Martinez-Marti A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten RD, Wakelee H, Camidge DR, Zalcman G, Novello S, Ou SI, Milia J, Gautschi O. Mazieres J, et al. Among authors: mascaux c. Ann Oncol. 2019 Aug 1;30(8):1321-1328. doi: 10.1093/annonc/mdz167. Ann Oncol. 2019. PMID: 31125062 Free PMC article.
Immune evasion before tumour invasion in early lung squamous carcinogenesis.
Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, Buttard B, Rothe F, Willard-Gallo K, Haller A, Ninane V, Burny A, Sculier JP, Spira A, Galon J. Mascaux C, et al. Nature. 2019 Jul;571(7766):570-575. doi: 10.1038/s41586-019-1330-0. Epub 2019 Jun 26. Nature. 2019. PMID: 31243362
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC).
Jeanson A, Tomasini P, Souquet-Bressand M, Brandone N, Boucekine M, Grangeon M, Chaleat S, Khobta N, Milia J, Mhanna L, Greillier L, Biemar J, Nanni I, Ouafik L, Garcia S, Mazières J, Barlesi F, Mascaux C. Jeanson A, et al. Among authors: mascaux c. J Thorac Oncol. 2019 Jun;14(6):1095-1101. doi: 10.1016/j.jtho.2019.01.011. Epub 2019 Feb 6. J Thorac Oncol. 2019. PMID: 30738221 Free article.
Evasion before invasion: Pre-cancer immunosurveillance.
Angelova M, Mascaux C, Galon J. Angelova M, et al. Among authors: mascaux c. Oncoimmunology. 2021 Apr 25;10(1):1912250. doi: 10.1080/2162402X.2021.1912250. Oncoimmunology. 2021. PMID: 33996263 Free PMC article.
Assessing therapy response in patient-derived xenografts.
Ortmann J, Rampášek L, Tai E, Mer AS, Shi R, Stewart EL, Mascaux C, Fares A, Pham NA, Beri G, Eeles C, Tkachuk D, Ho C, Sakashita S, Weiss J, Jiang X, Liu G, Cescon DW, O'Brien CA, Guo S, Tsao MS, Haibe-Kains B, Goldenberg A. Ortmann J, et al. Among authors: mascaux c. Sci Transl Med. 2021 Nov 17;13(620):eabf4969. doi: 10.1126/scitranslmed.abf4969. Epub 2021 Nov 17. Sci Transl Med. 2021. PMID: 34788078
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial.
Mazieres J, Lafitte C, Ricordel C, Greillier L, Negre E, Zalcman G, Domblides C, Madelaine J, Bennouna J, Mascaux C, Moro-Sibilot D, Pinquie F, Cortot AB, Otto J, Cadranel J, Langlais A, Morin F, Westeel V, Besse B. Mazieres J, et al. Among authors: mascaux c. J Clin Oncol. 2022 Mar 1;40(7):719-728. doi: 10.1200/JCO.21.01455. Epub 2022 Jan 24. J Clin Oncol. 2022. PMID: 35073148 Clinical Trial.
Personalised medicine for nonsmall cell lung cancer.
Mascaux C, Tomasini P, Greillier L, Barlesi F. Mascaux C, et al. Eur Respir Rev. 2017 Nov 15;26(146):170066. doi: 10.1183/16000617.0066-2017. Print 2017 Dec 31. Eur Respir Rev. 2017. PMID: 29141962 Free article. Review.
Biological basis of anemia.
Bron D, Meuleman N, Mascaux C. Bron D, et al. Among authors: mascaux c. Semin Oncol. 2001 Apr;28(2 Suppl 8):1-6. doi: 10.1016/s0093-7754(01)90205-2. Semin Oncol. 2001. PMID: 11395845 Review.
105 results